Employers, lawmakers, patient advocates, price transparency groups and more urged the U.S. Department of Labor to quickly finalize a rule that would force pharmacy benefit managers, shadowy middlemen ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果